Thank you to everyone who has responded so quickly in response to our requests for data entry and data amendments – this will finally be drawing to a close at the end of next week. If you have any remaining data queries at your site or have not yet entered the dasatinib transition data for your patients please do so prior to Monday 30th April.
We are now moving on to the next phase of the analysis preparation and therefore all eCRF user accounts will be deactivated during the week commencing the 30th April. This will prevent any changes being made to data which has now been checked and is ready for analysis.
PI accounts will remain live until the sign off approval process is complete, and any PIs without accounts currently will be granted one in order to complete the process. PIs will be contacted directly in the next couple of weeks regarding the data approval process for their site.
Once PIs have approved their site data, the database will be fully locked ready for final analysis.
Please get in contact with a member of the trial team if you have any issues, queries or concerns.
Last modified: Wed, 25 Apr 2018 14:01:00 BST